Cargando…
Clinical Characterization and Prognostic Value of TPM4 and Its Correlation with Epithelial–Mesenchymal Transition in Glioma
Tropomyosin 4 (TPM4) has been reported as an oncogenic gene across different malignancies. However, the role of TPM4 in glioma remains unclear. This study aimed to determine the clinical characterization and prognostic value of TPM4 in gliomas. Transcriptome expression and clinical information were...
Autores principales: | Wang, Jin, Yang, Ying, Du, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497136/ https://www.ncbi.nlm.nih.gov/pubmed/36138856 http://dx.doi.org/10.3390/brainsci12091120 |
Ejemplares similares
-
The prognostic value of TPM1–4 in hepatocellular carcinoma
por: Tian, Zhihui, et al.
Publicado: (2021) -
TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9
por: Chen, Sui, et al.
Publicado: (2021) -
The prognostic value of Tiam1 correlates with its roles in epithelial–mesenchymal transition progression and angiogenesis in lung adenocarcinoma
por: Zhu, Guang, et al.
Publicado: (2019) -
Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma
por: Li, Yao, et al.
Publicado: (2023) -
NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas
por: Sun, Huaiyu, et al.
Publicado: (2020)